Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy.
作者信息
Hathorn J W, Rubin M, Pizzo P A
机构信息
Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland 20892.
出版信息
Antimicrob Agents Chemother. 1987 Jul;31(7):971-7. doi: 10.1128/AAC.31.7.971.
Abstract
摘要
相似文献
1
Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy.发热性中性粒细胞减少癌症患者的经验性抗生素治疗：单一疗法的临床疗效及影响
Antimicrob Agents Chemother. 1987 Jul;31(7):971-7. doi: 10.1128/AAC.31.7.971.
2
Prospective randomly controlled trial of three antibiotic combinations for empirical therapy of suspected sepsis in neutropenic cancer patients.
Eur J Cancer (1965). 1975 Aug;11suppl:5-8. doi: 10.1016/b978-0-08-019964-1.50005-1.
3
Empirical antibiotic therapy in febrile patients with neutropenia and malignant disease.发热性中性粒细胞减少症和恶性疾病患者的经验性抗生素治疗。
Eur J Cancer (1965). 1973 Jun;9(6):417-23. doi: 10.1016/0014-2964(73)90106-0.
4
The febrile neutropenic patient: newer options for empirical therapy.
Haematol Blood Transfus. 1990;33:531-8. doi: 10.1007/978-3-642-74643-7_95.
5
Antibiotic choice in the neutropenic patient.中性粒细胞减少患者的抗生素选择
Del Med J. 1984 Jul;56(7):413-5.
6
The results of a randomized trial of empirical antibiotic treatment in febrile neutropenic patients with four beta-lactam/aminoglycoside combinations.一项针对发热性中性粒细胞减少患者采用四种β-内酰胺类/氨基糖苷类联合用药进行经验性抗生素治疗的随机试验结果。
J Antimicrob Chemother. 1983 May;11 Suppl C:57-63. doi: 10.1093/jac/11.suppl_c.57.
7
Antibiotic therapy for the febrile granulocytopenic cancer patient: combination therapy vs. monotherapy.
Rev Infect Dis. 1989 Nov-Dec;11 Suppl 7:S1572-81. doi: 10.1093/clinids/11.supplement_7.s1572.
8
Empirical antibiotics for febrile neutropenic cancer patients.发热性中性粒细胞减少癌症患者的经验性抗生素治疗。
Eur J Cancer Clin Oncol. 1989;25 Suppl 2:S43-51.
9
Current issues in the antibiotic primary management of the febrile neutropenic cancer patient: a perspective from the National Cancer Institute.
J Hosp Infect. 1990 Apr;15 Suppl A:41-8. doi: 10.1016/0195-6701(90)90078-3.
10
[Bacterial infections in neutropenic patients with cancer].[癌症中性粒细胞减少患者的细菌感染]
Przegl Lek. 2003;60 Suppl 5:54-7.
引用本文的文献
1
Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line-Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients.氟喹诺酮类药物预防用于自体干细胞移植患者中心静脉相关血流感染的效果非常好。
Biol Blood Marrow Transplant. 2019 May;25(5):1004-1010. doi: 10.1016/j.bbmt.2018.11.023. Epub 2018 Nov 24.
2
3
A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia.
Support Care Cancer. 2005 Jun;13(6):387-92. doi: 10.1007/s00520-004-0753-8. Epub 2004 Dec 15.
4
Methods of minimising the cost of aminoglycoside therapy to hospitals.降低医院氨基糖苷类药物治疗成本的方法。
Pharmacoeconomics. 1993 Mar;3(3):228-43. doi: 10.2165/00019053-199303030-00006.
5
Adverse effects of pefloxacin in irradiated C3H/HeN mice: correction with glucan therapy.培氟沙星对受辐照C3H/HeN小鼠的不良反应：葡聚糖治疗的纠正作用
Antimicrob Agents Chemother. 1993 Sep;37(9):1882-9. doi: 10.1128/AAC.37.9.1882.
6
Amikacin and ceftazidime as empirical antibiotic therapy in severely neutropenic patients: analysis of prognostic factors.
Support Care Cancer. 1994 Jul;2(4):259-65. doi: 10.1007/BF00365733.
7
Oral ofloxacin therapy of Pseudomonas aeruginosa sepsis in mice after irradiation.照射后小鼠铜绿假单胞菌败血症的口服氧氟沙星治疗
Antimicrob Agents Chemother. 1990 Jul;34(7):1387-9. doi: 10.1128/AAC.34.7.1387.
8
Beta-lactam antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivo.β-内酰胺类抗生素在体外和体内均能增强蛙皮抗菌肽2的抗菌活性。
Antimicrob Agents Chemother. 1991 Jun;35(6):1153-9. doi: 10.1128/AAC.35.6.1153.
9
Teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin in the treatment of febrile neutropenic patients.替考拉宁联合环丙沙星与庆大霉素联合哌拉西林治疗发热性中性粒细胞减少症患者的疗效比较
Eur J Clin Microbiol Infect Dis. 1992 Jun;11(6):509-14. doi: 10.1007/BF01960805.
本文引用的文献
1
Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia.表皮葡萄球菌：粒细胞减少症患者感染的一个日益常见的病因。
Ann Intern Med. 1982 Oct;97(4):503-8. doi: 10.7326/0003-4819-97-4-503.
2
Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia.针对长期发热且粒细胞减少的癌症患者的经验性抗生素和抗真菌治疗。
Am J Med. 1982 Jan;72(1):101-11. doi: 10.1016/0002-9343(82)90594-0.
3
Synergistic combinations of antibiotics in gram-negative bacillary infections.革兰氏阴性杆菌感染中抗生素的协同组合
Rev Infect Dis. 1982 Mar-Apr;4(2):294-301. doi: 10.1093/clinids/4.2.294.
4
Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy.接受免疫抑制治疗患者的凝固酶阴性葡萄球菌菌血症
Arch Intern Med. 1983 Jan;143(1):32-6.
5
The new beta-lactamase-stable cephalosporins.新型β-内酰胺酶稳定的头孢菌素。
Ann Intern Med. 1982 Sep;97(3):408-19. doi: 10.7326/0003-4819-97-3-408.
6
Imipenem therapy of Pseudomonas aeruginosa and other serious bacterial infections.亚胺培南治疗铜绿假单胞菌及其他严重细菌感染。
Antimicrob Agents Chemother. 1984 Nov;26(5):673-7. doi: 10.1128/AAC.26.5.673.
7
Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia.单药与联合经验性治疗用于伴有或不伴有粒细胞减少症的发热性癌症患者革兰氏阴性杆菌感染
Antimicrob Agents Chemother. 1984 Dec;26(6):870-5. doi: 10.1128/AAC.26.6.870.
8
Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients.
Am J Med. 1981 Dec;71(6):983-90. doi: 10.1016/0002-9343(81)90324-7.
9
Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patients.美洛西林作为发热性粒细胞缺乏癌症患者经验性单药治疗的潜力。
Antimicrob Agents Chemother. 1980 Aug;18(2):299-306. doi: 10.1128/AAC.18.2.299.
10
Mezlocillin for treatment of infections in cancer patients.美洛西林用于治疗癌症患者的感染。
Antimicrob Agents Chemother. 1980 Jun;17(6):1008-13. doi: 10.1128/AAC.17.6.1008.
Zotero 插件